-
Researchers decode neurological symptoms of coronavirus infection
expresspharma
June 01, 2020
The scientists said further studies involving brain scans and testing of CNS tissue will be crucial to understanding the biological process of the disease in the nervous system.
-
First COVID-19 vaccine human trial finds it is safe, induces immune response
expresspharma
May 27, 2020
According to the study of 108 adults, the vaccine produced neutralising antibodies, and a response mediated by the immune system's T-cells against the novel coronavirus, SARS-CoV-2.
-
Novavax launches trial of coronavirus vaccine candidate
pharmatimes
May 26, 2020
As of this morning – Tuesday May 26 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 261,184 with 36,914 deaths.
-
FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response
americanpharmaceuticalreview
May 21, 2020
We are announcing another step in our effort to harness diverse streams of data to understand and respond to COVID-19.
-
Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials
expresspharma
May 21, 2020
The data reported to Japan’s health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether the drug can be approved by the end of this month.
-
UK's coronavirus testing capacity has been 'inadequate', Committee finds
pharmatimes
May 20, 2020
A committee of MPs has concluded that the UK's testing capacity during the novel coronavirus outbreak 'has been inadequate for most of the pandemic so far'.
-
Coronavirus vaccine possible in about a year, says EU agency
expresspharma
May 15, 2020
"For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so beginning of 2021," said Marco Cavaleri, head of vaccines, European Medicines Agency.
-
Moderna gets FDA fast track status for mRNA vaccine against novel coronavirus
pharmaceutical-business-review.
May 14, 2020
Moderna has secured fast track designation from the US Food and Drug Administration (FDA) for its mRNA-1273, the mRNA vaccine candidate against the novel coronavirus (SARS-CoV-2).
-
HP University scientists gets Microsoft Grant for coronavirus research
expresspharma
May 14, 2020
The team will perform screening of phytochemical constituents for anti-viral activity through interaction with COVID-19 specific targets using molecular modelling studies.
-
Study reveals novel coronavirus may infect human intestines
expresspharma
May 14, 2020
Researchers were able to isolate SARS-CoV-2 from the stool specimen of a female patient diagnosed with COVID-19, which suggests that intestinal infection may have occurred.